Oxytocin increases the survival of musculocutaneous flaps

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 357, Issue 6, 1998, Pages 701-704

  Petersson, Maria ^a,b   Lundeberg, Thomas ^b   Sohlström, Annica ^b   Wiberg, Ursula ^b   Uvnäs Moberg, Kerstin ^b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Growth factors; IGF 1; Musculocutaneous flap; Oxytocin; Oxytocin antagonist; Rat; Wound healing

Indexed keywords

OXYTOCIN; OXYTOCIN ANTAGONIST; OXYTOCIN DERIVATIVE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GRAFT SURVIVAL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MYOCUTANEOUS FLAP; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; WOUND HEALING;

ANIMALS; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE, SKELETAL; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SKIN PHYSIOLOGY; SURGICAL FLAPS;

EID: 0031806129     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005227     Document Type: Article

References (21)

1. Ågren G, Lundeberg T, Uvnäs-Moberg K, Sato A (1995) The oxytocin antagonist 1-deamino-2-D-Tyr-(Oet)-4-Thr-8-Orn-oxytocin reverses the increase in the withdrawal response latency to thermal, but not mechanical nociceptive stimuli following oxytocin administration or massage-like stroking in rats. Neurosci Lett 187:49-52
2. Bang P. Wivall IL, Eriksson U, Sara V, Hall K (1991) Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: Improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol 124:620-629
3. Björkstrand E, Eriksson M, Uvnäs-Moberg K (1996) Evidence for a peripheral and a central effect of oxytocin on pancreatic hormone release in rats. Neuroendocrinology 63:377-383
4. Björkstrand E, Hulting AL, Uvnäs-Moberg K (1997) Evidence for a dual function of oxytocin in the control of growth hormone secretion in rats. Regul Pept 69:1-5
5. Cohick WS, Clemmons DR (1993) The insulin-like growth factors. Annu Rev Physiol 55:131-153
6. Eriksson M, Lundeberg T, Uvnäs-Moberg K (1996) Studies on cutaneous blood flow in the mammary gland of lactating rats. Acta Phys Scand 158:1-6
7. Gribbe Ö, Lundeberg T, Samuelsson UE, Wiklund NP (1997) Nitric oxide synthase activity and endothelial ultrastructure in ischaemic skin-flaps. Br J Plast Surg 50:483-490
8. Jacob R, Barrett E, Plewe G, Fagin KD, Sherwin RS (1989) Acute effects of insulin-like growth factor-1 on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. J Clin Invest 83:1717-1723
9. Kjartansson J, Dalsgaard, CJ (1987) Calcitonin gene-related peptide increases survival of a musculocutaneous flap in the rat. Eur J Pharmacol 142:355-358
10. Luppi P, Levi-Montalcini R, Bracci-Laudiero L, Bertolini A, Arletti R, Tavernari D, Vigneti E, Aloe L (1993) NGF is released into plasma during human pregnancy: an oxytocin-mediated response? Neuroreport 4:1063-1065
11. McFarlane RM, DeYoung G, Henry RA (1965) The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg 35:177-182
12. Mellin TN, Cashen DE, Ronan JJ, Murphy BS, DiSalvo J, Thomas KA (1995) Acidic fibroblast growth factor accelerates dermal wound healing in diabetic mice. J Invest Dermatol 104:850-855
13. Petersson M, Alster P, Lundeberg T, Uvnäs-Moberg K (1996) Oxytocin causes a long-term decrease of blood pressure in female and male rats. Phys Behav 60:1311-1315
14. Petersson M, Ahlenius S, Wiherg U, Alster P, Uvnäs-Moberg K (1998) Steroid dependent effects of oxytocin on spontaneous motor activity in female rats. Brain Res Bull 45:301-305
15. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Gramates P, Deuel TF (1989) Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci 86:2229-2233
16. Rodriguez-Tarduchy G, Collins MK, Garcia I, Lopez-Rivas A (1992) Insulin-like growth factor-1 inhibits apoptosis in IL-3-dependent hemopoetic cells. J Immunol 149:535-540
17. Schaeffer HJ, Sirotkin A (1995) The release of insulin-like growth factor-1 by luteinized human granulosa cells in vitro: Regulation by growth hormone, oxytocin, steroids and cAMP-dependent intracellular mechanisms. Exp Clin Endocrinol 103:361-366
18. Suh DY, Hunt TK, Spencer EM (1992) Insulin-like growth factor-1 reverses the impairment of wound healing induced by corticosteroids in rats. Endocrinology 131:2399-2403
19. Uvnäs-Moberg K, Ahlenius S, Hillegaart V, Alster P (1994) High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol Biochem Behav 49:101-106
20. Uvnäs-Moberg K, Alster P, Petersson M (1996) Dissociation of oxytocin effects on body weight in two variants of female Sprague-Dawley rats. Integr Physiol Behav Sci 31:44-55
21. Uvnäs-Moberg K, Alster P, Petersson M, Sohlström A, Björkstrand E (1998) Postnatal oxytocin injections cause sustained weight gain and increased nociceptive thresholds in male and female rats. Pediatr Res 43:344-348